PERSISTENCE WITH ANTI-OSTEOPOROTIC THERAPY IN PATIENTS WITH RHEUMATIC DISEASE

被引：0
|
作者：
Mizuki, S. [1 ]
Kushimoto, K. [1 ]
Yamasaki, H. [1 ]
Yoshida, K. [1 ]
Oryoji, K. [1 ]
Kamada, K. [1 ]
Yokota, E. [1 ]
机构：
[1] Matsuyama Red Cross Hosp, Ctr Rheumat Dis, Matsuyama, Ehime, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4191
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0486
引用
收藏
页码：367 / 367
页数：1
相关论文
共 50 条
  • [1] COMPLIANCE AND PERSISTENCE OF ANTI-OSTEOPOROTIC TREATMENTS IN PATIENTS WITH HIP FRACTURE
    Paredes, S.
    Guinovart, M.
    Basco, A.
    Llop, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1190 - 1191
  • [2] Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence
    C. Roerholt
    P. Eiken
    B. Abrahamsen
    Osteoporosis International, 2009, 20
  • [3] THE NEED FOR ANTI-OSTEOPOROTIC THERAPY IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Sorokina, A.
    Demin, N.
    Dobrovolskaya, O.
    Toroptsova, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1478 - 1478
  • [4] Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence
    Roerholt, C.
    Eiken, P.
    Abrahamsen, B.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (02) : 299 - 307
  • [5] ANTI-OSTEOPOROTIC THERAPY DECREASE CANCER RISK IN PATIENTS WITH OSTEOPOROTIC VERTEBRAL FRACTURES
    Chen, Y. -C.
    Ko, C. -H.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 690 - 690
  • [6] Anti-osteoporotic therapy in Denmark—predictors and demographics of poor refill compliance and poor persistence
    C. Hansen
    B. D. Pedersen
    H. Konradsen
    B. Abrahamsen
    Osteoporosis International, 2013, 24 : 2079 - 2097
  • [7] Anti-osteoporotic therapy in Denmark-predictors and demographics of poor refill compliance and poor persistence
    Hansen, C.
    Pedersen, B. D.
    Konradsen, H.
    Abrahamsen, B.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (07) : 2079 - 2097
  • [8] UTILISATION OF ANTI-OSTEOPOROTIC DRUGS IN REAL-WORLD DATA: AN ANALYSIS OF PERSISTENCE TO THERAPY AND RISK OF FRACTURE
    Orlando, V.
    Monetti, V. M.
    Guerriero, F.
    Moretti, A.
    Russo, V.
    Piscitelli, A.
    Iolascon, G.
    Menditto, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 446 - 446
  • [9] Is the current anti-osteoporotic therapy paradigm good enough?
    Fisher, Alexander A.
    Davis, Michael W.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (12) : 1960 - 1961
  • [10] IMPACT OF GLUCOCORTICOIDS AND ANTI-OSTEOPOROTIC TREATMENT ON BONE HEALTH IN PATIENTS WITH INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASES (IRMD)
    Adami, G.
    Fassio, A.
    Viapiana, O.
    Benini, C.
    Bertelle, D.
    Gatti, D.
    Rossini, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S356 - S357
12345